Back
EPAM Systems Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
19
EPAM
EPAM Systems
Last Price:
$176.65
Seasonality Move:
12.14%
Sell
48
APLS
Apellis Pharmaceuticals
Last Price:
$19.39
Seasonality Move:
2.19%
Sell
19
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy, Sell or Hold?
-
The current EPAM Systems [EPAM] share price is $178.23. The Score for EPAM is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.28. The Score for APLS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPAM Stock Price Chart
What is EPAM Systems's stock price today?
-
The EPAM Systems share price today is $178.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.28The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
EPAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.55 | Buy |
Relative Strength Index (14 RSI): | 55.76 | Buy |
Chaikin Money Flow: | 432290 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (167.41 - 184.73) | Buy |
Bollinger Bands (100): | (156.96 - 232.28) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 56.31 | Buy |
Chaikin Money Flow: | -736195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.94 - 19.02) | Buy |
Bollinger Bands (100): | (18.38 - 27.78) | Sell |
EPAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 174.48 | Buy |
20-day SMA: | 179.28 | Sell |
50-day SMA: | 165.74 | Buy |
200-day SMA: | 205.32 | Sell |
8-day EMA: | 175.79 | Buy |
20-day EMA: | 174.17 | Buy |
50-day EMA: | 151.91 | Buy |
200-day EMA: | 70.94 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.25 | Buy |
20-day SMA: | 17.72 | Buy |
50-day SMA: | 18.85 | Buy |
200-day SMA: | 27.74 | Sell |
8-day EMA: | 18.51 | Buy |
20-day EMA: | 18.21 | Buy |
50-day EMA: | 19.52 | Sell |
200-day EMA: | 27.76 | Sell |
EPAM Systems Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.66 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.04 per share, and an increase next year of $1.22 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
EPAM Systems Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |